Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Temp To Perm? Von Eschenbach Slated To Be Nominated As FDA Commissioner

This article was originally published in The Pink Sheet Daily

Executive Summary

The Bush Administration appears to be preparing to nominate FDA Acting Commissioner von Eschenbach as permanent agency head.

You may also be interested in...



Von Eschenbach Nominated For FDA Commissioner Under Threat Of Hold

Sens. Clinton (D-N.Y.) and Murray (D-Wash.) demand a decision on Plan B to avoid a hold, employing the same tactic they used during the confirmation of former Commissioner Lester Crawford.

Von Eschenbach Nominated For FDA Commissioner Under Threat Of Hold

Sens. Clinton (D-N.Y.) and Murray (D-Wash.) demand a decision on Plan B to avoid a hold, employing the same tactic they used during the confirmation of former Commissioner Lester Crawford.

FDA Hired An Independent Contractor To Analyze Plan B Comments, Von Eschenbach Says

FDA Acting Commissioner ducks questions from Rep. Sam Farr (D-Calif.) on a timeline for Plan B's OTC switch.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS063971

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel